Comparison of Eleven Commercial Tests for Chlamydia pneumoniae -Specific Immunoglobulin G in Asymptomatic Healthy Individuals
Open Access
- 1 May 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (5) , 1603-1609
- https://doi.org/10.1128/jcm.40.5.1603-1609.2002
Abstract
The seroprevalence of anti- Chlamydia pneumoniae -specific immunoglobulin G (IgG) antibodies is high in the adult population. Experience is required to perform a microimmunofluorescence test (MIF), the current “gold standard” for serological diagnosis, and the assay still lacks standardization. Partially automated enzyme-linked immunosorbent assays (ELISAs) and enzyme immunoassays (EIAs), which are more standardized and for which the reading of results is less subjective, have been developed. The different commercially available serological tests differ in their sensitivities and specificities, depending primarily on the antigen used. Therefore, we evaluated 11 different tests (10 were species specific, 1 was genus specific) for IgG antibodies using serum samples of 80 apparently healthy volunteers. The interpretation of the results was based on the results of the gold standard, MIF: a sample was judged positive if it was positive by at least three of the four different MIFs. Based on this internal standard, we found that 71% of the samples were positive, while 8% were false positive by some tests. The correlations between the results of the different MIFs ranged from 83 to 99%, and the correlations between the results of the MIFs and the different ELISAs and EIAs ranged from 78 to 98%. Comparison of the IgG titers measured by MIF showed good agreement ( r = 0.76 to 0.91). This analysis revealed that some ELISAs and EIAs fail to detect low IgG titers. The specificities of the species-specific tests varied from 95 to 100%, and the sensitivities varied from 58 to 100%. These results indicate that serological assays for the detection of anti- C. pneumoniae -specific IgG vary greatly in their sensitivities and specificities. MIF must still be considered the best method for the detection of IgG in apparently healthy subjects, but the sensitivities and specificities of new ELISAs approximate those of MIFs.Keywords
This publication has 53 references indexed in Scilit:
- Comparison of Two Commercial Microimmunofluorescence Kits and an Enzyme Immunoassay Kit for Detection of Serum Immunoglobulin G Antibodies to Chlamydia pneumoniaeClinical and Diagnostic Laboratory Immunology, 2001
- Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy IndividualsJournal of Clinical Microbiology, 2001
- Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniaeInfection and Immunity, 2000
- Detection of Chlamydia pneumoniae DNA and Antigen in the Circulating Mononuclear Cell Fractions of Humans and KoalasInfection and Immunity, 2000
- Chlamydia pneumoniaeDNA Detection in Peripheral Blood Mononuclear Cells Is Predictive of Vascular InfectionThe Journal of Infectious Diseases, 1999
- Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA959Journal of Medical Microbiology, 1997
- Review: Chlamydial lipopolysaccharideInnate Immunity, 1997
- Evaluation of serological methods in the diagnosis ofChlamydia pneumoniae pneumonia during an epidemic in FinlandEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infectionsCanadian Journal of Microbiology, 1992
- A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract InfectionsNew England Journal of Medicine, 1986